DJIA 17,804.80 26.65 0.15%
NASDAQ 4,765.38 16.98 0.36%
S&P 500 2,070.65 9.42 0.46%
market minute promo

company name or ticker

Spectrum Pharmaceuticals Inc Stock Downgraded (SPPI)

Spectrum Pharma Posts Lower Y/Y Q4 Earnings - Analyst Blog

Spectrum Pharmaceuticals Enters Oversold Territory (SPPI)

Analysis Of The Near-Term Value Drivers Of Spectrum Pharmaceuticals

Spectrum Pharmaceuticals Management Discusses Q4 2013 Results - Earnings Call Transcript

Spectrum Pharmaceuticals, Inc. Discusses Q4 2013 Results (Webcast)

Investors are betting against Spectrum Pharmaceuticals (SPPI), Should You? - Tale of the Tape

3 Under-the-Radar Biotech Stocks You Need to Watch in 2014

Nektar Therapeutics, Omeros, and Spectrum Pharmaceuticals all face off with regulators in key decision dates for their developmental drugs later this year

Biotech Stock 'Hate' Mailbag: Readers Riot Over Galena, Prana

Is Spectrum Pharmaceuticals, Inc. Blazing the Comeback Trail?

Spectrum Pharmaceuticals has been one of the rare losers in the biopharma sector. That trend may be set to change, however, as the company has set itself up for long-term growth.
See More Articles...